Table 13 Proposed data elements of the selected content for the system design (Section 3)
From: Development of minimum data set and electronic registry for hemodialysis patients management
Row | Section 3: Laboratory findings of hemodialysis patients | Strongly disagree | Disagree | Neither agree nor disagree | Agree | Strongly agree | Total answers | Confirmation /Revision/ Rejection | |
|---|---|---|---|---|---|---|---|---|---|
NO. (%) | NO. (%) | NO. (%) | NO. (%) | NO. (%) | NO. (%) | ||||
1 | monthly | Hgb | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed |
2 | PLt | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
3 | FBS | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed | |
4 | BUN | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed | |
5 | Na | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
6 | K | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed | |
7 | Ca | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed | |
8 | P | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed | |
9 | Hct | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
10 | quarterly | ALP | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed |
11 | Cr | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed | |
12 | iPTH | 0 (0) | 0 (0) | 0 (0) | 1 (9.1) | 10 (90.9) | 11 (100) | Confirmed | |
13 | Ferritin | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
14 | Iron | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
15 | TIBC | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
16 | Alb | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
17 | Chol | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
18 | TG | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
19 | Bicarbonate | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
20 | six-month | AST | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed |
21 | ALT | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
22 | HBS Ag | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
23 | HIV Ab | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
24 | HCV Ab | 0 (0) | 0 (0) | 1 (9.1) | 0 (0) | 10 (90.9) | 11 (100) | Confirmed | |
25 | annual | Al | 0 (0) | 0 (0) | 0 (0) | 2 (18.2) | 9 (81.8) | 11 (100) | Confirmed |
26 | Vitamin D | 0 (0) | 0 (0) | 2 (18.2) | 1 (9.1) | 8 (72.7) | 11 (100) | Confirmed | |